The TOR kinase integrates nutritional and stress signals to coordinately control cell growth in all eukaryotes. TOR associates to highly conserved proteins to constitute two distinct signaling complexes termed TORC1 and TORC2. Inactivation of TORC1 by rapamycin negatively regulates protein synthesis in most eukaryotes. Here we report that downregulation of TOR signaling by rapamycin in the model green alga 
INTRODUCTION
The abundance and quality of nutrients are key factors that determine cell growth (increase in cell mass) in all living organisms. In eukaryotes, the availability of nutrients as well as other environmental cues is transmitted to the cell growth machinery through a number of important signalling proteins including the target of rapamycin (TOR) kinase (for reviews see (Crespo and Hall, 2002; De Virgilio and Loewith, 2006; Wullschleger et al., 2006; Ma and Blenis, 2009; Sengupta et al., 2010) ). TOR is a Ser/Thr kinase that associates to other proteins to form two distinct multiprotein complexes, termed TORC1 and TORC2, which modulate two major signalling branches in eukaryotic cells (Hara et al., 2002; Kim et al., 2002; Loewith et al., 2002; Wedaman et al., 2003; Jacinto et al., 2004) . TOR and other core components of these two complexes are evolutionarily conserved from lower to higher eukaryotes, indicating that these proteins must play central roles in nutrient signalling (Wullschleger et al., 2006) .
The TOR pathway stimulates cell growth by promoting anabolic processes, including translation and ribosome biogenesis, and inhibiting catabolic processes such as autophagy (Crespo and Hall, 2002) . Control of protein synthesis is one of the bestcharacterized processes downstream of the TOR pathway. In yeast and mammals, TORC1 controls protein synthesis at different levels by positively regulating translation initiation and ribosome biogenesis (De Virgilio and Loewith, 2006; Ma and Blenis, 6 serine and threonine residues in the carboxy terminus of SCH9, and phosphorylated SCH9 participates in the activation of all three RNA polymerases (Urban et al., 2007) .
In mammalian cells, phosphorylated S6K promotes phosphorylation of the ribosomal protein S6, which in turn results in the up-regulation of translation initiation (Chung et al., 1992) . In addition to activating protein synthesis, TORC1 inhibits autophagy when nutrients are available (Noda and Ohsumi, 1998) . Autophagy is a membrane-trafficking process by which starved cells degrade and recycle cytosolic proteins and organelles.
During this catabolic process, cytosolic components are nonselectively enclosed within a double-membrane structure (autophagosome) and delivered to the vacuole/lysosome for degradation (Xie and Klionsky, 2007; Nakatogawa et al., 2009) . TORC1 has been identified as an essential component in transmitting nutrient starvation signals to the autophagic machinery in yeast and higher eukaryotes. TORC1 negatively controls autophagy via inhibition of the evolutionarily conserved protein kinase ATG1 that mediates an early activation step in the autophagic process (reviewed in (Diaz-Troya et al., 2008) ).
The TOR kinase has been described in plants and algae, indicating that this signalling pathway is also conserved in photosynthetic organisms (Menand et al., 2002; Crespo et al., 2005) . In both systems, TOR has been involved in cell growth control, since disruption of the AtTOR gene in Arabidopsis thaliana is lethal (Menand et al., 2002) , and rapamycin-mediated inactivation of CrTOR in Chlamydomonas reinhardtii results in strong inhibition of cell growth (Crespo et al., 2005) . Components of TORC1 signalling are conserved in Arabidopsis and Chlamydomonas. AtRaptor1 and Mahfouz et al., 2006) . Besides KOG1/raptor and TOR proteins, two putative LST8 homologues can be identified in the Arabidopsis genome (Moreau, 2010; Dobrenel et al., 2011) . In Chlamydomonas, it has been demonstrated that CrTOR localizes in highmolecular-mass complexes that include a highly conserved LST8 homologue (DiazTroya et al., 2008) . These findings indicate that TORC1 might be functionally and structurally conserved in photosynthetic eukaryotes. However, no obvious homologues exist for TORC2-specific partners in plants or algae (Moreau, 2010; Pérez-Pérez, 2010; Dobrenel et al., 2011) .
Dissection of the TOR pathway in plants has been hampered by the natural resistance of these organisms to rapamycin likely due to the inability of plant FKBP12 to bind to this drug (Xu et al., 1998) . Nevertheless, the generation of inducible RNAi lines that allow conditional silencing of the AtTOR gene (Deprost et al., 2007) or rapamycin-sensitive plants (Sormani et al., 2007; Leiber et al., 2010) have importantly contributed to understand how TOR controls plant cell growth. The finding that silencing of AtTOR expression arrests plant growth and reduces mRNA translation (Deprost et al., 2007) strongly suggests that control of protein synthesis by TOR is conserved in plants. Unlike plants, Chlamydomonas is sensitive to rapamycin and inactivation of TOR signalling by this drug leads to cell growth inhibition (Crespo et al., 2005) and autophagy activation (Perez-Perez and Crespo, 2010; Perez-Perez et al., 2010) , demonstrating that TOR controls this degradative process in photosynthetic organisms. Recently, it has also been shown that TOR inhibits autophagy in plants (Liu and Bassham, 2010) . Like in other systems, the identification of components of the TOR pathway in plants and algae will be essential to understand how TOR controls cell growth in these organisms. 
RESULTS

Rapamycin treatment induces threonine phosphorylation of a 70 kDa protein
In order to identify proteins regulated by TOR in Chlamydomonas and whose phosphorylation state is under the control of this signalling pathway, we performed western blot analysis of total extracts from Chlamydomonas cells treated with rapamycin using anti-phosphoserine (anti-P-Ser) and anti-phosphothreonine (anti-PThr) antibodies. Whereas no significant difference was observed in extracts from untreated cells compared to rapamycin-treated cells with the anti-P-Ser antibody, levels of Thr phosphorylation of a 70-kDa protein were increased, as detected with an anti-PThr antibody ( Figure 1A ). In order to resolve the 70 kDa molecular mass range, we conducted two-dimensional (2D) gel electrophoresis analysis of Chlamydomonas cells treated with rapamycin. Total extracts obtained from rapamycin-treated or untreated cells were subjected to isoelectric focusing followed by SDS-PAGE and examined by Coomassie staining and western blot with the anti-P-Thr antibody ( Figure 1B ). The comparative analysis of the different 2D gels obtained allowed us to identify a few spots in the 70 kDa region that become phosphorylated ( Figures 1B and 1C ). Three spots whose mobility was altered by rapamycin treatment were detected in untreated cells by Coomassie staining ( Figure 1C) . Accordingly, the signal obtained in this region with the anti-P-Thr antibody was more intense in rapamycin-treated cells, indicating the presence of phosphorylated proteins in at least some of these spots ( Figure 1B ).
Proteins present in the selected spots from control and treated samples were identified by mass spectrometry. Most of the spots included a mixture of three proteins that belong to the same category, namely HSP70B and the BiP1/BiP2 chaperones (Suppl. similar isoelectric points, which explains the co-migration in the same spots. However, these proteins are localized in different compartments of the cell since HSP70B resides in the chloroplast while BiP1/2 proteins are predicted to be ER proteins (Schroda, 2004) . BiP1 and BiP2 share 90% identity at the amino acid level, and both proteins were present from spot 1' to 5' from rapamycin-treated cells ( Figure 1C and Suppl. Table 1 ). Given the high identity of BiP1 and BiP2, these proteins could not be differentially identified by available antibodies, and we will therefore refer to them as BiP chaperones. In addition to the spots containing BiP and HSP70B proteins, other spots with reduced intensity were differentially detected in control and rapamycintreated samples with the anti-P-Thr antibody ( Figure 1B ). Some new spots were found in response to rapamycin treatment, indicating that other proteins became phosphorylated upon TOR inactivation. However, the identity of these proteins could not be verified.
Identification of BiP chaperones as the phosphorylated proteins upon TOR inhibition
The former experiments indicated that HSP70B and/or BiP might be modified by threonine phosphorylation in response to rapamycin-mediated inhibition of TOR signaling. To investigate whether this post-translational modification is due to an increase of newly synthesized protein or an induction of protein phosphorylation, HSP70B and BiP levels were analyzed by western blot. No significant accumulation of HSP70B or BiP chaperones was found after 8 hours of rapamycin addition to Chlamydomonas cultures, indicating that the signal detected by the anti-P-Thr antibody is due to an increase in protein phosphorylation (Figure 2A four to six hours of rapamycin addition (Figure 2A ). To demonstrate that this phosphorylation is specific to the inhibition of TOR signaling by rapamycin, we performed a similar experiment in the rapamycin resistant mutant rap2 that lacks the rapamycin primary target FKBP12 (Crespo et al., 2005) .
As expected, no phosphorylation induction was found in this mutant in response to rapamycin ( Figure   2A ).
Next, we investigated if the signal detected with the anti-P-Thr antibody is caused by the modification of HSP70B and BiP chaperones or only by one of these proteins. To this aim, we performed 2D gel electrophoresis followed by western blot analysis using antibodies specific to HSP70B or BiP. Samples were separated in the first dimension by isoelectric focusing in pH 4-7 strips in order to obtain a better resolution of HSP70B and BiP spots. The signal of the anti-P-Thr antibody was strongly induced in certain spots of rapamycin-treated cells ( Figure 2B ), indicating the modification of the protein(s) localized in these spots. The mobility of the HSP70B chaperone was not altered in response to rapamycin, which strongly suggests that this protein is not responsible for the increased signal obtained with the anti-P-Thr antibody ( Figure 2B ). We cannot exclude, however, the possibility that HSP70B is 
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in agreement with the faster phosphorylation of BiP detected with cycloheximide compared to rapamycin treatments ( Figure 3A) . Thus, our results strongly suggest that BiP phosphorylation occurred primarily in response to a decrease in the rate of protein synthesis.
Dephosphorylation of BiP correlates with chaperone activation
In general, chaperone activity of BiP is up-regulated under stress conditions that increase the level of misfolded proteins in the ER (Otero et al., 2010) . Stress-induced activation of BiP has been correlated with in vivo dephosphorylation of the protein in mammalian cells (Hendershot et al., 1988; Freiden et al., 1992; Satoh et al., 1993) . To investigate whether threonine phosphorylation of BiP detected in Chlamydomonas is related with a regulatory mechanism of this protein, Chlamydomonas cells were subjected to heat stress and the phosphorylation state of BiP was examined. Basal phosphorylation level of BiP was strongly reduced within 15 min of heat shock, being undetectable after 60 min ( Figure 4A ). 2D gel electrophoresis analysis of heat shocked cells further confirmed that this stress caused the complete dephosphorylation of all spots initially detected in untreated cells with the anti-P-Thr antibody ( Figure 2B ).
Dephosphorylation of BiP by heat shock was also determined in cells that have been previously treated with rapamycin to increase the phosphorylation level of BiP prior to heat stress. Heat shock also resulted in undetectable levels of BiP phosphorylation despite the elevated modification of the chaperone after rapamycin treatment ( Figure   4B ). These results indicated that BiP is dephosphorylated upon heat shock likely due to increased levels of unfolded polypeptides in the ER.
To strengthen this model, a specific stress in the ER was generated by treating 
The highly conserved Thr520 plays a role in BiP function
To further characterize the modification of BiP, we tried to identify rapamycinsensitive phosphorylation sites by mass spectrometry (MS). Total extracts from untreated or rapamycin-treated cells were resolved by 2D gel electrophoresis and BiP proteins were excised from the gel, digested with the endoproteinase GluC and analyzed by MS for phosphopeptide identification (see Materials and Methods) . ( Figure 5A ). An alignment of BiP proteins from different organisms revealed that a threonine residue (Thr520 in Chlamydomonas BiP1) from this phosphopeptide is widely conserved within eukaryotes ( Figure 5B ). Interestingly, a modelling study of BiP1 indicated that Thr520 might be in an exposed region of the chaperone accessible to other proteins ( Figure 5C ) while the NetPhosK server (Blom et al., 2004) predicted Thr520 as the residue with the highest probability of phosphorylation in BiP1. Our results therefore indicated that inhibition of TOR signalling by rapamycin leads to phosphorylation of BiP in a conserved region of the peptide-binding domain and strongly suggested that Thr520 might play an important role in this modification.
To explore this hypothesis, we performed a functional study of Chlamydomonas molecular mass ( Figure 6B ). It is well established that KAR2 is itself translocated into the ER in yeast via a mechanism that depends on KAR2 function, and mature and precursor forms of the protein can be detected under certain circumstances (Rose et al., 1989; Vogel et al., 1990) . Therefore, the lower mobility band of BiP1 might very likely correspond to the precursor form of the protein that cannot be properly translocated into the ER.
With the availability of a functional assay for Chlamydomonas BiP1, we next investigated whether the conserved Thr520 of this protein is involved in BiP function.
Thr520 was replaced by Ala, Glu or Arg, and the point mutants (T520A, T520E and T520R, respectively) were expressed in yeast cells. Similar to wild-type BiP1, T520A
and T520R proteins were able to promote growth of kar2-159 cells at 30ºC ( Figure 6A ). However, T520E mutation, which mimics a constitutive phosphorylation of the residue, could not fully complement BiP function at 30ºC, indicating that T520E mutation decreased BiP function ( Figure 6A ). None of the BiP1 mutants were able to promote growth at 37ºC ( Figure 6A ). Interestingly, all mutations in Thr520 resulted in a pronounced increase in the abundance of the precursor and mature forms of this protein in yeast cells compared to wild-type BiP1 ( Figure 6B ), which indicates that this residue is important for the stability and processing of BiP1 in yeast cells.
Cellular relocalization of BiP upon ER stress induced by tunicamycin
BiP has been localized in Chlamydomonas to discrete punctae all over the cell that are more abundant around the flagellar basal bodies ((Diaz-Troya et al., 2008) and 
DISCUSSION
We have previously reported that, unlike plants, growth of Chlamydomonas cells is sensitive to rapamycin, indicating that a rapamycin-sensitive TOR pathway operates in this unicellular green alga to govern cell growth (Crespo et al., 2005; DiazTroya et al., 2008) . In this study we show that inactivation of TOR signalling by rapamycin caused inhibition of protein synthesis in Chlamydomonas ( Figure 3B ), which demonstrates that TOR promotes protein synthesis in this photosynthetic organism. additional phosphorylation sites (Figures 1 to 4) . Post-translational modification of BiP, including phosphorylation and ADP-ribosylation, has been previously reported in mammalian cells (Carlsson and Lazarides, 1983; Welch et al., 1983; Hendershot et al., 1988; Freiden et al., 1992) . Phosphoamino acid analysis of purified mammalian BiP demonstrated that this protein is predominantly phosphorylated on threonine residues with only a trace of detectable phosphoserine (Hendershot et al., 1988; Gaut, 1997) .
Moreover, in vivo threonine phosphorylation has been mapped to a region of the peptide-binding domain of mammalian BiP (Gaut, 1997) adjacent to the phosphopeptide identified in Chlamydomonas BiP ( Figure 5 ).
Modification of mammalian BiP by phosphorylation or ADP-ribosylation seems to be restricted to a pool of BiP that does not bind to substrate proteins (Hendershot et al., 1988; Freiden et al., 1992) . Furthermore, it has been demonstrated that stresses which increase the need for active BiP in mammalian cells such as glucose starvation or tunicamycin treatment promote dephosphorylation of BiP and its association with proteins (Hendershot et al., 1988; Satoh et al., 1993) . These findings led to the theory that modified BiP represents an inactive form of the protein, and that unmodified BiP is able to bind to proteins and promote their folding and assembly (Hendershot et al., 1988) . It has been also proposed that post-translational modification of BiP might provide a storage pool of BiP that can be recruited back to the active form in response to need (Gething, 1999) . The present study strongly suggests that regulation of BiP by phosphorylation is conserved in the photosynthetic alga Chlamydomonas, and assigns a 
MATERIALS AND METHODS
Strains and Growth Conditions
Chlamydomonas reinhardtii wild-type strain 6C+ was obtained from the laboratory of J.-D. Rochaix (University of Geneva), and rapamycin-insensitive rap2 strain has been previously described (Crespo et al., 2005) . Cells were grown as described by Harris (1989) under continuous illumination at 25ºC. If required, Trisacetate phosphate medium (TAP) was solidified with 1.2% Bacto agar (Difco). When specified, cells were treated with 500 nM rapamycin (LC Labs) from a 4 mM stock in 90% ethanol-10% Tween20, 5 μg/ml tunicamycin (Calbiochem) from a 5 mg/ml stock in dimethylformamide, or 10 μg/ml cycloheximide (Sigma) from a 3 mg/ml stock in water. Saccharomyces cerevisiae wild-type (MS10) and kar2-159 were obtained from the laboratory of M. D. Rose. YJL034W (KAR2) heterozygous mutant was obtained from the EUROSCARF mutant collection. Yeast cells were grown in rich or synthetic medium as previously described (Sherman, 1991) .
Protein preparation
Chlamydomonas cells from liquid cultures were collected by centrifugation (3000 x g, 5 min), washed once in lysis buffer (50 mM Tris-HCl (pH 7.5), 10 mM NaF, 10 mM NaN 3 , 10 mM p-Nitrophenylphosphate, 10 mM NaPPi, 10 mM betaglycerophosphate), and resuspended in a minimal volume of the same solution supplemented with Protease Inhibitor Cocktail (Sigma). Cells were lysed by two cycles of slow freezing to -80ºC followed by thawing to room temperature. The soluble cell extract was separated from the insoluble fraction by centrifugation (15700 x g, 15 min) at 4ºC, and stored at -80ºC until they were analyzed. Yeast extracts from logarithmically growing cells were prepared in lysis buffer (PBS buffer, 1 mM PMSF, 0.5% Tween20, 10 mM NaF, 10 mM NaN 3 , 10 mM p-Nitrophenylphosphate, 10 mM NaPPi, 10 mM beta-glycerophosphate) by vortexing them 10 times for 1 min each time with glass beads (Sigma-Aldrich). Crude extracts were cleared by centrifugation at 15,000g for 15 min at 4_C. Proteins were quantitated with the Coomassie dye binding method (BioRad). Following overnight active rehydration (50V, 20°C), IEF was performed for 15kVh (for pH 3-10NL strips) or 20kVh (for pH 4-7 strips) at 20°C using the Protean IEF Cell (Bio-Rad). After the first dimension separation, strips were blotted to remove mineral oil and stored at -80°C. Prior to the second dimension separation (SDS-PAGE), thawed strips were first equilibrated with 10 mg/ml DTT in equilibration buffer (6 M urea, 75 mM Tris-HCl pH 8.8, 29,3% glycerol, 2% SDS, and 0.002% bromophenol blue), and then with 25 mg/ml iodoacetamide in equilibration buffer. A RE 600 Ruby chamber system (GE Healthcare) was used for the second dimension separation.
2D gel electrophoresis
Equilibrated strips were placed on 10% SDS-PAGE gels and sealed with 0.5% agarose.
Proteins were separated by molecular weight using a 70 mA constant intensity. Gels were Coomassie blue stained or processed for western blot. 
Western blotting
Proteins resolved by SDS-PAGE or 2D-gel electrophoresis were transferred to PVDF membrane (for phosphothreonine detection) or nitrocellulose membrane (for BiP, HSP70B and FKBP12 detection) for antibody binding. Immunoblots were visualized using horseradish peroxidase-conjugated secondary antibodies (Sigma) and the ECL Plus chemiluminescent system (GE Healthcare). The Chlamydomonas FKBP12 polyclonal antibody has been described previously (Crespo et al., 2005) . The Arabidopsis BiP, Chlamydomonas HSP70-B, and phosphothreonine polyclonal antibodies were purchased from Santa Cruz Biotechnology, Agrisera, and Zymed Laboratories, respectively. The KAR2 antibody was obtained from Santa Cruz Biotechnology.
Fluorescence Microscopy
Wild-type Chlamydomonas cells were fixed and stained for IF microscopy as CBB-stained proteins were excised from the gel using the EXQuest Spot Cutter excision robot (BioRad) and in-gel trypsin digested using a Proteineer dp Digester (Bruker Daltonics). Gel plugs were incubated in acetonitrile (50 µl), and treated with 10 mM DTT in 50 mM ammonium bicarbonate followed by 55 mM iodoacetamide in 50 mM ammonium bicarbonate. Trypsin digestion was performed at 30°C for 4 h using 13 μ g/ml trypsin in 50 mM ammonium bicarbonate. Digestion was stopped and peptides extracted using 0.5% trifluoroacetic acid. Tryptic digests were analysed using an Autoflex MALDI-TOF instrument (Bruker Daltonics, Billerica, MA, USA) and proteins were identified as the highest ranked result by searching the NCBI non- μl/min. After 15 min, the trap column was switched into the flow path of the C18 separating column (0.1 x 150 mm, Swiss Bioanalytics, Birsfelden, CH). A linear gradient from 2 to 35% solvent B in solvent A in 60 min was delivered with an Agilent 1200 nano pump at a flow rate of 300 nl/min. After 60 min the percentage of solvent B was increased to 60% in ten minutes and further increased to 80% within 2 min. The eluting peptides were ionized at 1.7 kV. The mass spectrometer was operated in a datadependent fashion. The precursor scan was done in the Orbitrap set to 60,000 resolution, while the fragment ions were mass analyzed in the LTQ instrument. A top five method was run so that the five most intense precursors were selected for fragmentation. The MS/MS spectra were then searched against the NCBI nonredundant database, version from August 2008, using TurboSequest software (Gatlin et al., 2000) . The databank was searched with Bioworks version 3.3.1. SP1 by setting the precursor ion tolerance to 10 ppm, while the fragment ion tolerance was set to 0.5 Da.
Cleavage rules were set to Fully enzymatic -cleaves at both ends, allowing 2 missed cleavages. The modifications were set to carbamidomethyl cysteine as fixed modification, while phosphorylation on Ser/Thr, and Tyr was set to variable modifications. Post filtering was set to the following parameters: ΔCN, 0.1; Xcorr versus charge state was 1.50 (1+), 2.00 (2+), 2.50 (3+); peptide probability, 0.01; protein probability 0.01.
Cloning of Chlamydomonas BiP1 and plasmid construction
The BiP1 coding region from Chlamydomonas (1971 bp) was amplified by PCR from a Chlamydomonas cDNA library using the following primers: BiP1 SpeI 5' (5'-CCGGACTAGTATGGCGCAGTGGAAGGCTGCTGTGCTG-3') and BiP1 SpeI 3' (5'-GATCTTCTCCTTCTTGCCGCGGCCCTTGTCCTCAGCGGC-3'). The final PCR products were cloned into p425GPD for expression in yeast cells.
Labelling of cells with [ 14 C]arginine
Cell labelling was performed essentially as described in Stavis and Hirschberg in the light with gentle shaking. Samples of 0.1 ml were collected and added to 0.5 ml of cold 10% trichloroacetic acid (TCA). The precipitated material was collected on
Whatman glass fiber filters, washed four times with cold 5% TCA, dried, and radioactivity measured by a liquid scintillation counter. resolved by 2D electrophoresis as described in Experimental Procedures using pH 4-7 strips and gels were processed for immunodetection with phosphothreonine (P-Thr), BiP and HSP70B specific antibodies. A, Western blot analysis of Chlamydomonas soluble extracts with phosphoserine (P-Ser) and phosphothreonine (P-Thr) antibodies. Log-phase wild-type cells were treated with 500 nM rapamycin (rap) or drug vehicle and samples were taken at the indicated times. Soluble extracts were fractionated by SDS-PAGE and analyzed by western blot. The asterisk denotes the 70 kDa band detected with the P-Thr antibody. B, Soluble extracts of Chlamydomonas cells treated (rap) or not (control) with 500 nM rapamycin for 8 hours were resolved by 2D electrophoresis as described in Experimental Procedures. Gels were stained with Coomassie Brilliant Blue (CBB) or processed for immunodetection with the phospho-threonine (P-Thr) antibody. C, Enlarged images of box sections in 2D gels shown in panel B. Arrow indicates spots whose mobility differs in untreated and rapamycin-treated cells. Numbers refer to spots where proteins have been identified by mass spectrometry (see Suppl. 70 kDa protein following rapamycin treatment. 500 nM rapamycin or drug vehicle were added to wild-type (wt) or rapamycin-insensitive (rap2) Chlamydomonas cells and samples were collected at the indicated times. Soluble extracts were fractionated by SDS-PAGE and analyzed by western blotting probing with phosphothreonine (P-Thr), BiP and HSP70B specific antibodies. B, 2D western blot analysis of BiP and HSP70B. Wild type Chlamydomonas cells were treated with 500 nM rapamycin for 12 hours (rap), heat shocked at 40ºC for 1 hour (HS) or remained untreated (control). Soluble extracts were resolved by 2D electrophoresis as described in Experimental Procedures using pH 4-7 strips and gels were processed for immunodetection with phosphothreonine (P-Thr), BiP and HSP70B specific antibodies. Chlamydomonas cells were treated with 500nM rapamycin for 6 hours (rap), 10 μg/ml cycloheximide for 30 min (CHX), or drug vehicle (C) and processed for the analysis of [14C]arginine incorporation as described in Experimental Procedures. Values are represented in relation to the [14C]arginine incorporation detected in control, untreated cells and correspond to six independent determinations (*p<0.05, **p<0.01). C, Effect of CHX and rapamycin on protein synthesis. Chlamydomonas cultures were treated with 500 nM rapamycin (triangles) or 10 μg/ml CHX (circles) or drug vehicle (squares) and samples were taken at different times for protein synthesis determination. Data correspond to results from three independent experiments made in duplicate. Figure 4. BiP dephosphorylation by ER stress-inducing agents. BiP dephosphorylation by heat stress. Chlamydomonas cells pretreated (B) or not (A) with 500 nM rapamycin (rap) for 12 hours were subjected to heat stress at 40ºC and samples were taken at the indicated times. Soluble extracts were fractionated by SDS-PAGE and analyzed by western blot probing with P-Thr and BiP specific antibodies. C, BiP dephosphorylation by tunicamycin treatment. Chlamydomonas cells were treated with 500 nM rapamycin (rap), 5 μg/ml tunicamycin (tun), or first treated with rapamycin (rap, lane 8) and then with tunicamycin (rap tun, lane 9). Samples were taken at the indicated times and soluble extracts were processed and analyzed by western blot. 
